Financing channel feed

SPAC bust: ARCH, Deer­field and Sec­tion 32 can­cel their $200M life sci­ences bet

Last year

Lon­za cites biotech fund­ing slow­down as it low­ers sales out­look for the year

Last year
Manufacturing

Part­nered with Lil­ly, TVM Cap­i­tal and Tillotts fund oral in­flam­ma­to­ry bow­el dis­ease drug with up to $28M

Last year
Startups

Turn­stone Bi­o­log­ics rides biotech's IPO train in Fri­day de­but

Last year
Startups

Scoop: CNS biotech Map­Light Ther­a­peu­tics eyes $175M raise for PhII clin­i­cal tri­als in schiz­o­phre­nia, autism and Parkin­son's

Last year
Startups

Fol­low­ing Dupix­ent’s rise, Sanofi heads down­stream in im­munol­o­gy for $125M small mol­e­cule pact with Re­cludix

Last year
Startups
Deals

Biotech’s op­ti­mism is re­turn­ing amid signs of a bet­ter sec­ond half and a brighter 2024

Last year
Startups
Deals

Har­row prices $60M of­fer­ing one day af­ter ac­quir­ing US, Cana­di­an rights to new dry eye treat­ment

Last year

Im­munother­a­py dur­ing surgery? Surge Ther­a­peu­tics nabs $32M to ex­pand clin­i­cal plans af­ter first dos­ing

Last year

Rid­ing on pos­i­tive da­ta, ar­genx rais­es $1.1B while Alzheimer's biotech Acu­men lands $130M

Last year

Ar­genx launch­es $750M of­fer­ing af­ter PhII da­ta drop

Last year

Ex­clu­sive: Texas biotech rais­es $47M to move heart surgery drug in­to piv­otal study

Last year

Turn­stone charts $75M IPO for TIL cell ther­a­pies in drum­roll of biotech IPOs this month

Last year
Startups

West­lake at­tracts an­oth­er $450M to fu­el star­tups in LA's nascent biotech scene

Last year
Startups

UK's life sci­ences sec­tor sees $1.1B drop in for­eign in­vest­ments from 2021 to 2022

Last year
Pharma

Up­dat­ed: In Fri­day IPO dou­ble­head­er, Apogee and Sagimet help crack open a stuck win­dow on Wall Street

Last year
Startups

Causaly, an AI start­up help­ing with pre­clin­i­cal dis­cov­ery, nabs $60M from VCs and for­mer J&J chief Alex Gorsky

Last year
Startups
AI

UK VC firm launch­es strate­gic re­view, pon­ders shut­down

Last year

Bio­Gen­er­a­tion Ven­tures clos­es $167M fund to hatch Eu­ro­pean star­tups with back­ing from Eli Lil­ly, No­vo, BMS

Last year
Startups

San Diego biotech se­cures $75M to ad­vance lead can­di­date

Last year

Tril­lion-dol­lar part­ner: Re­cur­sion rais­es $50M from Nvidia, stock sky­rock­ets

Last year
AI

Ten­point Ther­a­peu­tics launch­es with $70M to re­store vi­sion with stem cell ther­a­pies and ‘re­pro­gram­ming’ med­i­cines

Last year
Startups
Cell/Gene Tx

Ex­clu­sive: Brig­gs Mor­rison's Cross­bow Ther­a­peu­tics nabs $80M from MPM, Pfiz­er Ven­tures, Lil­ly in hunt for bet­ter can­cer drugs

Last year
Startups

Ex­clu­sive: Pfiz­er to in­vest $25M in­to tiny UK biotech with epi­ge­net­ics ap­proach to can­cer

Last year
Deals
First page Previous page 29303132333435 Next page Last page
A service from the Financial Times